LWM Advisory Services LLC Purchases New Position in The Clorox Company (NYSE:CLX)

LWM Advisory Services LLC purchased a new stake in shares of The Clorox Company (NYSE:CLXFree Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund purchased 1,500 shares of the company’s stock, valued at approximately $214,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CLX. Vanguard Group Inc. lifted its position in shares of Clorox by 0.3% during the third quarter. Vanguard Group Inc. now owns 15,341,234 shares of the company’s stock valued at $2,010,622,000 after purchasing an additional 44,344 shares in the last quarter. FMR LLC lifted its position in shares of Clorox by 17.4% during the 3rd quarter. FMR LLC now owns 2,415,054 shares of the company’s stock worth $316,517,000 after buying an additional 357,964 shares in the last quarter. Stifel Financial Corp boosted its stake in shares of Clorox by 2.2% in the 3rd quarter. Stifel Financial Corp now owns 2,184,875 shares of the company’s stock worth $286,356,000 after buying an additional 47,879 shares during the last quarter. Morgan Stanley grew its holdings in shares of Clorox by 1.8% in the third quarter. Morgan Stanley now owns 1,738,928 shares of the company’s stock valued at $227,904,000 after acquiring an additional 30,902 shares in the last quarter. Finally, Northern Trust Corp grew its holdings in shares of Clorox by 2.7% in the third quarter. Northern Trust Corp now owns 1,633,624 shares of the company’s stock valued at $214,103,000 after acquiring an additional 42,352 shares in the last quarter. 78.53% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

CLX has been the topic of several research analyst reports. Jefferies Financial Group raised Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price objective on the stock in a research report on Tuesday, March 26th. Morgan Stanley reissued an “equal weight” rating and issued a $160.00 price target on shares of Clorox in a report on Tuesday, March 26th. JPMorgan Chase & Co. raised their price objective on shares of Clorox from $145.00 to $152.00 and gave the stock a “neutral” rating in a report on Thursday, January 18th. Citigroup reduced their target price on shares of Clorox from $165.00 to $155.00 and set a “neutral” rating for the company in a research report on Tuesday, April 16th. Finally, DA Davidson restated a “neutral” rating and set a $162.00 price target on shares of Clorox in a research note on Wednesday, April 17th. Four investment analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $148.63.

Read Our Latest Research Report on CLX

Clorox Stock Performance

Shares of NYSE:CLX traded up $2.44 during midday trading on Monday, reaching $148.92. 1,659,853 shares of the company traded hands, compared to its average volume of 1,210,226. The firm’s fifty day moving average price is $149.39 and its two-hundred day moving average price is $142.74. The firm has a market capitalization of $18.48 billion, a price-to-earnings ratio of 233.61, a price-to-earnings-growth ratio of 2.32 and a beta of 0.43. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 11.37. The Clorox Company has a 12 month low of $114.68 and a 12 month high of $178.21.

Clorox (NYSE:CLXGet Free Report) last announced its quarterly earnings results on Thursday, February 1st. The company reported $2.16 earnings per share for the quarter, beating the consensus estimate of $1.08 by $1.08. The firm had revenue of $1.99 billion for the quarter, compared to analysts’ expectations of $1.80 billion. Clorox had a return on equity of 319.41% and a net margin of 1.09%. The company’s revenue was up 16.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.98 earnings per share. On average, equities analysts expect that The Clorox Company will post 5.52 earnings per share for the current year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th will be given a dividend of $1.20 per share. The ex-dividend date of this dividend is Tuesday, April 23rd. This represents a $4.80 dividend on an annualized basis and a dividend yield of 3.22%. Clorox’s dividend payout ratio (DPR) is currently 761.92%.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.